263 related articles for article (PubMed ID: 14997042)
1. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
[TBL] [Abstract][Full Text] [Related]
2. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
[TBL] [Abstract][Full Text] [Related]
4. Expression of the nerve growth factor receptors TrkA and p75 in malignant mesothelioma.
Davidson B; Reich R; Lazarovici P; Flørenes VA; Risberg B; Nielsen S; Sert B; Bedrossian C
Lung Cancer; 2004 May; 44(2):159-65. PubMed ID: 15084380
[TBL] [Abstract][Full Text] [Related]
5. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
7. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
8. The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Abeler VM; Kopolovic J; Onsrud M; Lazarovici P; Davidson B
Hum Pathol; 2007 Jan; 38(1):140-6. PubMed ID: 16996570
[TBL] [Abstract][Full Text] [Related]
9. Expression of nerve growth factor receptors and their prognostic value in human breast cancer.
Descamps S; Pawlowski V; Révillion F; Hornez L; Hebbar M; Boilly B; Hondermarck H; Peyrat JP
Cancer Res; 2001 Jun; 61(11):4337-40. PubMed ID: 11389056
[TBL] [Abstract][Full Text] [Related]
10. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma.
Davidson B; Konstantinovsky S; Kleinberg L; Nguyen MT; Bassarova A; Kvalheim G; Nesland JM; Reich R
Gynecol Oncol; 2006 Sep; 102(3):453-61. PubMed ID: 16494928
[TBL] [Abstract][Full Text] [Related]
11. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
Bock AJ; Nymoen DA; Brenne K; Kærn J; Davidson B
Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113
[TBL] [Abstract][Full Text] [Related]
12. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
13. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors.
Yuan Y; Leszczynska M; Konstantinovsky S; Tropé CG; Reich R; Davidson B
Diagn Cytopathol; 2011 Aug; 39(8):562-6. PubMed ID: 20730893
[TBL] [Abstract][Full Text] [Related]
14. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
[TBL] [Abstract][Full Text] [Related]
15. Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer.
Dang C; Zhang Y; Ma Q; Shimahara Y
J Gastroenterol Hepatol; 2006 May; 21(5):850-8. PubMed ID: 16704535
[TBL] [Abstract][Full Text] [Related]
16. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
Kleinberg L; Dong HP; Holth A; Risberg B; Trope' CG; Nesland JM; Flørenes VA; Davidson B
Hum Pathol; 2009 Jun; 40(6):795-806. PubMed ID: 19157506
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.
Davidson B; Xi Z; Klokk TI; Tropé CG; Dørum A; Scheistrøen M; Saatcioglu F
Am J Clin Pathol; 2005 Mar; 123(3):360-8. PubMed ID: 15716231
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion?
Kolokythas A; Cox DP; Dekker N; Schmidt BL
J Oral Maxillofac Surg; 2010 Jun; 68(6):1290-5. PubMed ID: 20363547
[TBL] [Abstract][Full Text] [Related]
19. Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells.
Park JB; Lee CK; Koh JS; Lee JK; Park EY; Riew KD
Spine (Phila Pa 1976); 2007 Aug; 32(18):1969-73. PubMed ID: 17700442
[TBL] [Abstract][Full Text] [Related]
20. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
